My watch list
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
My watch list
My saved searches
My saved topics
Propentofylline is a xanthine derivative and phosphodiesterase inhibitor with purported neuroprotective effects. It is being studied as a possible treatment for Alzheimer's disease and multi-infarct dementia. 
Propentofylline has also been studied, to a lesser extent, as a possible adjunct in the treatment of ischemic stroke, due to its
vasodilating properties. 
 See also
^ Frampton M, Harvey RJ, Kirchner V (2003). "Propentofylline for dementia". Cochrane database of systematic reviews (Online) (2): CD002853. doi:10.1002/14651858.CD002853. PMID 12804440.
^ Kittner B, Rössner M, Rother M (1997). "Clinical trials in dementia with propentofylline". Ann. N. Y. Acad. Sci. 826: 307–16. PMID 9329701.
^ Bath PM, Bath-Hextall FJ (2004). "Pentoxifylline, propentofylline and pentifylline for acute ischaemic stroke". Cochrane database of systematic reviews (Online) (3): CD000162. doi:10.1002/14651858.CD000162.pub2. PMID 15266424. ^ Huber M, Kittner B, Hojer C, Fink GR, Neveling M, Heiss WD (1993). "Effect of propentofylline on regional cerebral glucose metabolism in acute ischemic stroke". J. Cereb. Blood Flow Metab. 13 (3): 526–30. PMID 8478410.
This article is licensed under the
GNU Free Documentation License. It uses material from the Wikipedia article "Propentofylline". A list of authors is available in Wikipedia.
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE